Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ALEC | Common Stock | Options Exercise | $341K | +19.8K | +19.31% | $17.23 | 122K | Dec 8, 2021 | Direct | F1 |
transaction | ALEC | Common Stock | Options Exercise | $565K | +55.2K | +45.08% | $10.24 | 178K | Dec 8, 2021 | Direct | |
transaction | ALEC | Common Stock | Sale | -$824K | -36.5K | -20.56% | $22.56 | 141K | Dec 8, 2021 | Direct | F2, F3 |
transaction | ALEC | Common Stock | Sale | -$886K | -38.5K | -27.28% | $23.01 | 103K | Dec 8, 2021 | Direct | F2, F4 |
transaction | ALEC | Common Stock | Options Exercise | $1.29M | +75K | +73.1% | $17.23 | 178K | Dec 9, 2021 | Direct | |
transaction | ALEC | Common Stock | Sale | -$1.65M | -72.4K | -40.74% | $22.80 | 105K | Dec 9, 2021 | Direct | F2, F5 |
transaction | ALEC | Common Stock | Sale | -$61.9K | -2.64K | -2.51% | $23.40 | 103K | Dec 9, 2021 | Direct | F2, F6 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ALEC | Employee Stock Option (right to buy) | Options Exercise | $0 | -19.8K | -3.6% | $0.00 | 530K | Dec 8, 2021 | Common Stock | 19.8K | $17.23 | Direct | F7 |
transaction | ALEC | Employee Stock Option (right to buy) | Options Exercise | $0 | -55.2K | -29.17% | $0.00 | 134K | Dec 8, 2021 | Common Stock | 55.2K | $10.24 | Direct | F8 |
transaction | ALEC | Employee Stock Option (right to buy) | Options Exercise | $0 | -75K | -14.15% | $0.00 | 455K | Dec 9, 2021 | Common Stock | 75K | $17.23 | Direct | F7 |
Id | Content |
---|---|
F1 | Includes 755 shares acquired on December 1, 2020 and 1,843 shares acquired on June 1, 2021 pursuant to the Issuer's employee stock purchase plan. |
F2 | The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. |
F3 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.94 to $22.92, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (6) to this Form 4. |
F4 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.94 to $23.10, inclusive. |
F5 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.36 to $23.35, inclusive. |
F6 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.36 to $23.44, inclusive. |
F7 | One-fourth of the shares subject to the option grant vested on December 9, 2020, and 1/48th vest monthly thereafter. |
F8 | The shares subject to the option vest in 48 equal monthly installments beginning on November 1, 2020. |